CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GEN - Genetic Engineering & Biotech News
Original article

Digitize or Fall Behind

Neutral
AI Analysis

Summary

Autolomous CEO Alexander Seyf argues that digitization, collaboration, and sharing of failed experiment data are critical to accelerating innovation in bioprocessing for cell and gene therapy, positioning data management as the primary obstacle rather than scientific challenges.

Importance:2/10
Sentiment:
0.00
digitizationbioprocessingcell and gene therapydata managementinnovation
Related Companies

Read the original article

Published by GEN - Genetic Engineering & Biotech News on July 1, 2026 4:00 PM

Read Original